ENGINEERED INFLUENZA ANTIGENIC POLYPEPTIDES AND IMMUNOGENIC COMPOSITIONS THEREOF - Patent 3303368

(19)

(11)

EP 3 303 368 A2

(12)

(88)	Date of publication A3:
	12.01.2017

(43)	Date of publication:
	11.04.2018 Bulletin 2018/15

(21)	Application number: 16732382.3

(22)	Date of filing: 02.06.2016

(51)

International Patent Classification (IPC):

C07K 14/005^(2006.01)

(86)	International application number:
	PCT/US2016/035594

(87)	International publication number:
	WO 2016/196846 (08.12.2016 Gazette 2016/49)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	MA MD

(30)

Priority:

02.06.2015 US 201562169814 P

(71)	Applicant: Sanofi Pasteur Inc.
	Swiftwater, PA 18370 (US)

(72)	Inventors:
	STRUGNELL, Tod Cambridge, MA 02139 (US) OLOO, Eliud Cambridge, MA 02139 (US) OOMEN, Raymond Cambridge, MA 02139 (US)

(74)	Representative: Høiberg P/S
	Adelgade 12 1304 Copenhagen K 1304 Copenhagen K (DK)

(54)	ENGINEERED INFLUENZA ANTIGENIC POLYPEPTIDES AND IMMUNOGENIC COMPOSITIONS THEREOF